WDTN Dayton news: FDA approves first melanoma cellular therapy
March 6, 2024
The University of Cincinnati's Trisha Wise-Draper, MD, PhD, spoke with WDTN Dayton to discuss the approval of Amtagvi, the first cellular therapy for metastatic or unresectable melanoma, a harmful skin cancer.